- Oncothyreon (ONTY -0.9%) appoints Scott Myers as CEO effective April 4. He joins the firm from Aerocrine AB where he was also CEO. He replaces interim CEO Chairman Chris Henney, Ph.D., D.Sc. who filled in after Robert Kirkman retired in early January.